NEW YORK and GUANGZHOU, China, Aug.
7, 2012 /PRNewswire/ -- Tanke BioSciences
Corporation (OTCQB: TNBI) today said it has introduced a
diverse array of water-soluble organic feed additives for the farm
animal market. These additives -- comprising multi-vitamins joined
with organic trace minerals -- are known to play a primary role in
fostering optimal animal growth and health, said Tanke, and are
generally considered easier to administer, more speedily digested,
and more effective than their dry feed additive counterparts.
Currently, Tanke's new sales division markets one water-soluble
organic feed additive product to the larger animal farms in seven
of China's 22 provinces. By the
end of this year the company expects to have completed development
of four additional water-soluble organic products, three of which
will be marketed by the new sales division to animal farms
throughout China. The remaining
product will be marketed by Tanke's original sales force to major
seafood farms across the nation.
Revenue from these products is expected to increase quarter by
quarter, said CEO and chairman Mr. Guixiong Qiu, and represent five
to ten percent of total revenue in 2013 and 2014.
Additional revenue, however, may materialize from other new
organic trace mineral products, said Mr. Qiu, including a line of
proprietary feed additives aimed at strengthening farm animals'
resistance against cancer and other major diseases. These products
are formulated on the mineral selenium, which has thus far
demonstrated impressive results in boosting animals' immune
systems.
Tanke is currently China's
largest producer of organic trace mineral additives, with some
seven percent of the market.
About Tanke BioSciences Corporation
Founded in 1997, Tanke BioSciences Corp. (http://tanke-bio.com/)
is a leading China-based agritech
company developing, manufacturing and marketing animal feed
additives and livestock nutritional products that address
China's soaring demand for safe,
reasonably priced food. All Tanke products are free of genetically
modified organisms (GMOs), antibiotics, and are
environment-friendly, making them optimal for animal consumption.
The company's operations are based in Guangzhou, China, and its chief financial
officer is located in New York
City. For investor information, please go to
http://ir.stockpr.com/tankebio/overview.
Forward-Looking Statements
This press release and the statements of representatives of our
officers, directors, employees and representatives related thereto
contain or may contain forward-looking statements which are based
upon the current beliefs and expectations of our management. Such
statements contained in this release are based on management's
exercise of business judgment as well as assumptions made by and
information currently available to management. When used in this
document, the words "guidance," "projects," "may," "could,"
"would," "should," "believes," "expects," "anticipates,"
"estimates," "intends," "plans," "ultimately" and words of similar
import, are intended to identify any forward-looking statements.
The information contained in the forward looking statements is
inherently uncertain, and our actual results may differ materially
due to a number of factors, many of which are beyond our ability to
predict or control, including, among others: (i) changes in the
level of consumer spending or preferences or demand for our
products; (ii) pressures from competition; (iii) our ability to
hire and retain key personnel and our relationship with our
employees; (iv) the performance of our distributors and other key
vendors; (v) effectively carrying out and managing our growth
strategies; (vi) failure to maintain the value and image of our
brand and protect our intellectual property rights; (vii)
seasonality; (viii) costs of materials and labor; (ix) sales,
manufacturing, supply or distribution difficulties or disruptions;
(x) compliance with or changes in Chinese, U.S. or international
laws and regulations; (xi) costs as a result of operating as a
public company; (xii) material weaknesses in internal controls;
(xiii) interest rate and foreign currency risks; (xiv) our ability
to maintain our land use and drug manufacturing rights in
China; (xv) general economic and
industry conditions in China and
internationally, and other risks as more fully detailed in our
filings with the Securities and Exchange Commission ("SEC"). Our
filings with the SEC are available at www.sec.gov. You are urged to
consider these factors carefully in evaluating our forward-looking
statements and are cautioned not to place undue reliance on such
forward-looking statements which are qualified in their entirety by
this cautionary statement. The forward-looking statements speak
only as of the date on which they are made, and the company
undertakes no obligation to publicly update such forward-looking
statements to reflect subsequent events or circumstances unless as
required by applicable laws or regulations.
Investor Contact:
Jimmy Caplan
Market Makers
(512) 329-9505
jimmycaplan@me.com
Media Contact:
Rick Eisenberg
Eisenberg Communications
(917) 691-8934
eiscom@msn.com
Company Contact:
Gilbert Lee
CFO
Tanke BioSciences Corp.
(214) 906-0065
glee@tanke-bio.com
SOURCE Tanke BioSciences Corporation
